Resources

Explore our online resource catalog to discover publications, presentations, tools, and related resources for global health practitioners, decision-makers, advocates, and more.

All resources

Read our latest

2396 Result s
2396 Result s
    Date
    From
    To
  1. Ethiopia introduced human papillomavirus (HPV) vaccination in December 2018 to reduce the risk of HPV-associated cancers. Initially administered as a two-dose schedule to 14-year-old girls, the country adopted a single-dose strategy in 2023. Coverage estimates¹ for 2023 ranged from 56 to 86 percent, highlighting gaps in reaching eligible girls, particularly those out of school or in hard-to-reach areas. Learn more about the key takeaways from multistakeholder consultation workshops.
    Published: October 2026
    Resource Page
    Part of a Series, Fact Sheet
  2. Kenya introduced human papillomavirus (HPV) vaccination into its routine immunization schedule in October 2019 to protect against HPV-associated cancers. The program targets ten-year-old girls through a mixed-delivery model combining primarily facility-based services with school-based outreach. HPV1 coverage reached 33 percent in 2020. Learn more about the key takeaways from multistakeholder consultation workshops.
    Published: October 2026
    Resource Page
    Part of a Series, Fact Sheet
  3. The Lao People’s Democratic Republic (Lao PDR) introduced human papillomavirus (HPV) vaccination into its routine immunization schedule in 2020 to help reduce the risk of HPV-associated cancers. The school-based program targets girls aged 10 to 14 and achieved HPV1 coverage of over 80 percent. However, gaps remain in reaching girls who are out of school or living in hard-to-reach areas. Learn more about the key takeaways from multistakeholder consultation workshops.
    Published: October 2026
    Resource Page
    Part of a Series, Fact Sheet
  4. Malawi introduced the human papillomavirus (HPV) vaccine into its national immunization program in January 2019 to help reduce the risk of HPV-associated cancers. The program targets nine-year-old girls, with an estimated 91 percent of eligible girls vaccinated in 2025. However, gaps remain in reaching girls who are out of school or living in hard-to-reach areas. Learn more about the key takeaways from multistakeholder consultation workshops.
    Published: October 2026
    Resource Page
    Part of a Series, Fact Sheet
  5. Nigeria introduced the human papillomavirus (HPV) vaccine into its national immunization program in October 2023 to reduce the risk of HPV-associated cancers. The program targets girls aged 9 to 14, with initial uptake reaching 80 percent in targeted areas during the campaign weeks. However, gaps remain in reaching girls who are out of school or living in hard-to-reach areas. Learn more about the key takeaways from multistakeholder consultation workshops.
    Published: October 2026
    Resource Page
    Part of a Series, Fact Sheet